IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v12y1983i1p15-36.html
   My bibliography  Save this article

A bibliometric analysis of pharmaceutical research

Author

Listed:
  • Koenig, Michael E. D.

Abstract

No abstract is available for this item.

Suggested Citation

  • Koenig, Michael E. D., 1983. "A bibliometric analysis of pharmaceutical research," Research Policy, Elsevier, vol. 12(1), pages 15-36, February.
    • Handle: RePEc:eee:respol:v:12:y:1983:i:1:p:15-36
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/0048-7333(83)90024-0
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Michael E. D. Koenig & Elizabeth M. Mezick, 2004. "Impact of mergers & acquisitions on research productivity within the pharmaceutical industry," Scientometrics, Springer;Akadémiai Kiadó, vol. 59(1), pages 157-169, January.
    2. Rebecca Henderson & Iain Cockburn, 1994. "Measuring Competence? Exploring Firm Effects in Pharmaceutical Research," Strategic Management Journal, Wiley Blackwell, vol. 15(S1), pages 63-84, December.
    3. John R. Hauser, 1998. "Research, Development, and Engineering Metrics," Management Science, INFORMS, vol. 44(12-Part-1), pages 1670-1689, December.
    4. Dar-Zen Chen & Wen-Yau Cathy Lin & Mu-Hsuan Huang, 2007. "Using Essential Patent Index and Essential Technological Strength to evaluate industrial technological innovation competitiveness," Scientometrics, Springer;Akadémiai Kiadó, vol. 71(1), pages 101-116, April.
    5. Rotolo, Daniele & Camerani, Roberto & Grassano, Nicola & Martin, Ben R., 2022. "Why do firms publish? A systematic literature review and a conceptual framework," Research Policy, Elsevier, vol. 51(10).
    6. Paul Muller & Julien Pénin, 2007. "Why do firms disclose knowledge and how does it matter?," Springer Books, in: Uwe Cantner & Franco Malerba (ed.), Innovation, Industrial Dynamics and Structural Transformation, pages 149-172, Springer.
    7. Ashish Arora & Sharon Belenzon & Andrea Patacconi, 2015. "Killing the Golden Goose? The Decline of Science in Corporate R&D," NBER Working Papers 20902, National Bureau of Economic Research, Inc.
    8. Sternitzke, Christian, 2010. "Knowledge sources, patent protection, and commercialization of pharmaceutical innovations," Research Policy, Elsevier, vol. 39(6), pages 810-821, July.
    9. Julien PENIN, 2005. "Open knowledge disclosure, incomplete information and collective innovations," Working Papers of BETA 2005-10, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
    10. Anna Giunta & Filippo M. Pericoli & Eleonora Pierucci, 2016. "University–Industry collaboration in the biopharmaceuticals: the Italian case," The Journal of Technology Transfer, Springer, vol. 41(4), pages 818-840, August.
    11. Lauriane Dewulf & Michele Cincera, 2018. "Academic Scientists: The Golden Opportunity For High-Tech Companies," Working Papers TIMES² 2018-030, ULB -- Universite Libre de Bruxelles.
    12. M. Marchi & M. Rocchi, 1999. "Summing up approaches to the study of science and technology indicators," Scientometrics, Springer;Akadémiai Kiadó, vol. 46(1), pages 39-49, September.
    13. Clara Calero & Thed N. Leeuwen & Robert J. W. Tijssen, 2007. "Research cooperation within the bio-pharmaceutical industry: Network analyses of co-publications within and between firms," Scientometrics, Springer;Akadémiai Kiadó, vol. 71(1), pages 87-99, April.
    14. Fumihiko Isada & Yuriko Isada, 2015. "A Network Analysis Of Open Innovation In Drug Discovery," Economy & Business Journal, International Scientific Publications, Bulgaria, vol. 9(1), pages 94-110.
    15. Salandra, Rossella, 2018. "Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting," Research Policy, Elsevier, vol. 47(7), pages 1215-1228.
    16. Julien Pénin, 2007. "Open Knowledge Disclosure: An Overview Of The Evidence And Economic Motivations," Journal of Economic Surveys, Wiley Blackwell, vol. 21(2), pages 326-347, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:12:y:1983:i:1:p:15-36. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.